<--- Back to Details
First PageDocument Content
Neuroimaging / Medical physics / Brain / Magnetic resonance imaging / Neuroinformatics / Outline of brain mapping / Medical imaging / Functional magnetic resonance imaging / Peter T. Fox / Single-photon emission computed tomography / Positron emission tomography / Neuropsychology
Date: 2011-08-31 09:27:59
Neuroimaging
Medical physics
Brain
Magnetic resonance imaging
Neuroinformatics
Outline of brain mapping
Medical imaging
Functional magnetic resonance imaging
Peter T. Fox
Single-photon emission computed tomography
Positron emission tomography
Neuropsychology

PERSPECTIVES OPINION Mapping context and content: the BrainMap model

Add to Reading List

Source URL: www.brainmap.org

Download Document from Source Website

File Size: 93,04 KB

Share Document on Facebook

Similar Documents

What Is PET? Positron Emission Tomography (PET) is a non-invasive form of medical imaging approved by Medicare for diagnosis and management of several forms of cancer including: 	 Lung Cancer

What Is PET? Positron Emission Tomography (PET) is a non-invasive form of medical imaging approved by Medicare for diagnosis and management of several forms of cancer including: Lung Cancer

DocID: 1uv0l - View Document

Determining the diagnostic kinetics of viral encephalitis using positron emission tomography (PET) in Münster Nicholas King, Discipline of Pathology, Bosch Institute, School of Medical Sciences, Sydney Medical School, U

Determining the diagnostic kinetics of viral encephalitis using positron emission tomography (PET) in Münster Nicholas King, Discipline of Pathology, Bosch Institute, School of Medical Sciences, Sydney Medical School, U

DocID: 1rQ7R - View Document

Histopathologic Features that Influence the Detection of Occult Lymph Node Metastasis Using PET/CT Imaging with Anti-PSMA Df-IAB2M in Newly Diagnosed High Risk Prostate Cancer Patients. 89Zr-  Bernard M. Gburek1, Anthony

Histopathologic Features that Influence the Detection of Occult Lymph Node Metastasis Using PET/CT Imaging with Anti-PSMA Df-IAB2M in Newly Diagnosed High Risk Prostate Cancer Patients. 89Zr- Bernard M. Gburek1, Anthony

DocID: 1rqYg - View Document

THE U~VERSITY OF NEW MEXICO COLLEGE OF PHARMACY ALBUQUERQUE, NEW MEXICO

THE U~VERSITY OF NEW MEXICO COLLEGE OF PHARMACY ALBUQUERQUE, NEW MEXICO

DocID: 1riLo - View Document

Microsoft Word - 25-32_FINAL_SN0302.doc

Microsoft Word - 25-32_FINAL_SN0302.doc

DocID: 1rbdW - View Document